Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion center [0.03%]
从专职的干细胞移植病房向输血科前瞻性转变血小板生产分析
Joerg-Peter Sigle,Michael Medinger,Martin Stern et al.
Joerg-Peter Sigle et al.
Background and objectives: Specialized centers claim a need for blood component production independent from the general blood transfusion services. We performed a prospective change control analysis of the transfer of pla...
Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases [0.03%]
血浆置换治疗中毒性表皮坏死松解症的疗效观察：四例报告
Milan Koštál,Milan Bláha,Miriam Lánská et al.
Milan Koštál et al.
Introduction: Toxic epidermal necrolysis (TEN) is a rare, life-threatening disease with a high mortality rate that is linked to drug toxicity. There is a lack of data about the underlying pathophysiologic mechanisms and t...
Case Reports
Journal of clinical apheresis. 2012;27(4):215-20. DOI:10.1002/jca.21213 2012
Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany [0.03%]
Trima Accel® v5.2采集高血小板计数献血者的高剂量浓缩血小板及同期采集血浆在德国的应用评估
M Daskalakis,C Schulz-Huotari,M Burger et al.
M Daskalakis et al.
Background and objectives: This study was undertaken to test the ability of Trima Accel® version 5.2 to simultaneously collect concentrated high-dose leukoreduced platelet products and double doses of plasma. ...
Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: a case report [0.03%]
肺炎链球菌相关溶血性尿毒综合征的治疗性血浆置换疗法：1例报告
Melissa L Petras,Nancy M Dunbar,James J Filiano et al.
Melissa L Petras et al.
Streptococcus pneumoniae-associated hemolytic uremic syndrome (pHUS) is an atypical form of HUS associated with microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. Although less common than diarrhea-associated HUS, ...
Case Reports
Journal of clinical apheresis. 2012;27(4):212-4. DOI:10.1002/jca.21208 2012
Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure [0.03%]
等容性血液稀释-红细胞交换在预防镰状细胞性贫血患者脑血管意外中的标准操作程序
Karén Matevosyan,Christina Anderson,Ravi Sarode
Karén Matevosyan
Red blood cell exchange is an accepted superior therapy to simple chronic transfusion, due to minimal risk of iron overload, for secondary prevention of cerebrovascular accidents in selected patients with sickle cell anemia. Recently, we de...
Hiba Alhumaidan,Joseph Sweeney
Hiba Alhumaidan
The storage of platelets in additive solution (PAS) had lagged behind red cell concentrates, especially in North America. The partial or complete removal of anticoagulated plasma and storage of platelet concentrates in AS presents many adva...
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells [0.03%]
plerixafor作为实时抢救策略用于动员自体CD34+细胞效果不佳的患者体内造血干细胞的效果
Ajay K Gopal,Mehdi Karami,JoAl Mayor et al.
Ajay K Gopal et al.
Plerixafor enhances CD34(+) cell mobilization, however, its optimal use is unknown. We hypothesized that plerixafor could "rescue" patients in the midst of mobilization when factors indicated a poor CD34(+) yield. Of 295 consecutive autolog...
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center study [0.03%]
中国成人NHL和HL患者动员不足的预测因素：单中心14年研究经验
Xiaohong Han,Li Ma,Lingdi Zhao et al.
Xiaohong Han et al.
Background: Factors affecting progenitor cell mobilization in patients with non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL) are incompletely understood. The aim of this retrospective study was to determine which ...
ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption [0.03%]
采用再生型选择性免疫球蛋白吸附术的ABO血型不合肾移植
Sven Teschner,Dirk Stippel,Roland Grunenberg et al.
Sven Teschner et al.
Background: ABO-incompatible (ABOi) kidney transplantation is an established procedure relying on the removal of donor-specific isoagglutinine antibodies as part of the recipient preconditioning. At present, current proto...